Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 608 | 1,051 | 1,076 | 836 | 894 |
Cost of Goods | 1,137 | 385 | 287 | 350 | 324 |
Gross Profit | -529 | 666 | 789 | 486 | 569 |
Operating Expenses | 7,132 | 5,045 | 5,432 | 5,936 | 5,753 |
Operating Income | -7,525 | -3,994 | -4,356 | -5,100 | -4,860 |
Interest Expense | 187 | 197 | 189 | 1,650 | 81 |
Other Income | 4,894 | 518 | 300 | 0 | -276 |
Pre-tax Income | -2,818 | -3,673 | -4,245 | -6,750 | -5,216 |
Net Income Continuous | -2,818 | -3,673 | -4,245 | -6,750 | -5,216 |
Net Income | $-2,818 | $-3,673 | $-4,245 | $-6,750 | $-5,216 |
EPS Basic Total Ops | -950.00 | -3,572.00 | -7,030.00 | 171,060.00 | -38,160.00 |
EPS Basic Continuous Ops | -950.32 | -3,571.55 | -7,029.96 | 170,974.70 | -38,145.09 |
EPS Diluted Total Ops | -950.00 | -3,572.00 | -7,030.00 | 171,060.00 | -38,160.00 |
EPS Diluted Continuous Ops | -950.32 | -3,571.55 | -7,029.96 | 170,974.70 | -38,145.09 |
EBITDA(a) | $-6,864 | $-3,332 | $-3,703 | $-3,000 | $-4,044 |